Document:

Exhibit
4.6

 

 

 

VIQ
Solutions Inc.

 

 

2021
Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

(Expressed
in United States dollars)

 

 

 

https://viqsolutions.com/

 

     

     

    

 

VIQ
SOLUTIONS INC.

 

VIQ Solutions
Inc.

Management’s
Discussion and Analysis of Financial Condition and Results of Operations for 2021

 

 

The
following Management’s Discussion and Analysis (“MD&A”) comments on the financial condition and results of operations
of VIQ Solutions Inc. (“VIQ” or the “Company”) for the three months ended March 31, 2021. The information
contained herein should be read in conjunction with the Q1 2021 unaudited condensed consolidated interim financial statements prepared
in accordance to International Financial Reporting Standards (“IFRS”). This MD&A should also be read in conjunction with
our annual MD&A and audited financial statements for the years ended December 31, 2020 and 2019, which we prepared in accordance
with IFRS and are available on SEDAR at www.sedar.com.

 

Certain
information included herein is forward-looking and based upon assumptions and anticipated results that are subject to uncertainties.
Should one or more of these uncertainties materialize or should the underlying assumptions prove incorrect, actual results may vary significantly
from those expected. See “Forward-Looking Statements” and “Risk Factors”. The information in this discussion
is provided as of May 13, 2021 unless we indicate otherwise.

 

Unless
the context otherwise requires, all references to “VIQ”, “Company”, “VIQ Solutions”, “our”,
 “us”, and “we” refer to VIQ Solutions Inc. and its subsidiaries. Additional information regarding the Company
is available on SEDAR at www.sedar.com.

 

As
a result of the Company’s graduation to TSX, there will be no further trading of VIQ shares on TSX-V after January 20, 2021.
VIQ’s common shares were delisted from TSX-V at the commencement of trading on TSX. The trading symbol for the common shares of
VIQ on TSX will remain unchanged as “VQS.”

 

All
amounts herein are presented in United States dollars, unless otherwise indicated.

 

Forward-looking
Statements

 

This
MD&A contains forward-looking statements about our achievements, the future success of our business and technology strategies, performance,
goals and other future events. Management’s assessment of future plans and operations, cash flows, methods of financing and the
ability to fund financial liabilities, and the timing of and impact of adoption of IFRS and other accounting policies may constitute
forward-looking statements under applicable securities laws and necessarily involve risks including, without limitation, the risks identified
below including COVID-19 pandemic globally.

 

As
a consequence, the Company’s actual results may differ materially from those expressed in, or implied by, the forward-looking statements.
Forward-looking statements or information are based on a number of factors and assumptions which have been used to develop such statements
and information, but which may prove to be incorrect. Although VIQ Solutions believes that the expectations reflected in such forward-looking
statements or information are reasonable, undue reliance should not be placed on forward-looking statements because the Company can give
no assurance that such expectations will prove to be correct.

 

    	MANAGEMENT DISCUSSION & ANALYSIS 	PAGE 1

     

    

 

VIQ
SOLUTIONS INC.

 

VIQ Solutions
Inc.

Management’s
Discussion and Analysis of Financial Condition and Results of Operations for 2021

 

 

In
addition to other factors and assumptions which may be identified in this document and other documents filed by the Company,
assumptions have been made regarding, among other things: the impact of increasing competition; the general stability of the
economic and political environment in which VIQ Solutions operates, including significant changes in demand from our clients as a
result of the impact of a global economic crisis and capital markets weakness; the risk of potential non-performance by
counterparties, including but not limited to, clients and suppliers, during uncertain economic conditions; our dependence on a
limited number of clients; our dependence on industries affected by rapid technological change; our ability to successfully manage
our operations internationally including in the United Kingdom, Australia and the United States; the challenge of managing
our financial exposures to foreign currency fluctuations; our ability to obtain qualified staff and services in a timely and
cost-efficient manner; our ability to obtain financing on acceptable terms including anticipated sources of funding of working
capital and financial losses which may include securing credit facilities, accessing new equity, corporate acquisitions or business
combinations or joint venture arrangements; the ability to secure new contracts on terms acceptable to the Company; the ability to
successfully develop new products; the Company's ability to effectively register, for protection, its new and existing products in
certain jurisdictions; the Company's ability to protect new and existing products from proprietary infringement by third parties and
its ability to effectively enforce such proprietary infringements; taxes in the jurisdictions in which the Company operates,
including Canada, the United Kingdom, Australia and the United States; and VIQ Solutions' ability to successfully market its
products. Readers are cautioned that the foregoing list of factors is not exhaustive.

 

The
purpose of the forward-looking statements is to provide the reader with a description of management’s expectations regarding the
Company’s 2021 outlook and may not be appropriate for other purposes. Readers are encouraged to read the section entitled “Risk
Factors” in this MD&A for a broader discussion of the factors that could affect our future performance. Furthermore, the forward-looking
statements contained in this document are made as at the date of this document and the Company does not undertake any obligation to update
publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise,
except as may be required by applicable securities laws.

 

Non-IFRS
Measures

 

The
Company prepares its financial statements in accordance with IFRS. Non-IFRS measures are used by management to provide additional insight
into our performance and financial condition. We believe non- IFRS measures are an important part of the financial reporting process
and are useful in communicating information that complements and supplements the consolidated financial statements. This MD&A also
includes certain measures which have not been prepared in accordance with IFRS such as, Adjusted EBITDA. To evaluate the Company’s
operating performance as a complement to results provided in accordance with IFRS, the term “Adjusted EBITDA”, as defined
by management, refers to net income (loss) before adjusting earnings for stock-based compensation, depreciation, amortization, interest
expense, accretion and other financing expense, (gain) loss on revaluation of conversion feature liability, loss on repayment of long-term
debt, restructuring costs, other expense (income), foreign exchange (gain) loss, current and deferred income tax expense (recovery).
We believe that the items excluded from Adjusted EBITDA are not connected to and do not represent the operating performance of the Company.

 

We
believe that Adjusted EBITDA is useful supplemental information as it provides an indication of the results generated by the Company’s
main business activities prior to taking into consideration how those activities are financed and taxed as well as expenses related to
stock-based compensation, depreciation, amortization, restructuring costs, other expense (income), and foreign exchange (gain) loss.
Accordingly, we believe that this measure may also be useful to investors in enhancing their understanding of the Company’s operating
performance. 

 

    	MANAGEMENT DISCUSSION & ANALYSIS 	PAGE 2

     

    

 

VIQ SOLUTIONS INC.

 

 

VIQ Solutions
Inc.

Management’s
Discussion and Analysis of Financial Condition and Results of Operations for 2021

 

 Adjusted
EBITDA is not a measure which has any standardized meaning under IFRS and therefore, may not be comparable to similar measures
presented by other issuers. Investors are cautioned that Adjusted EBITDA should not be construed as an alternative to net income
(loss) as determined in accordance with IFRS.

 

Overview

 

VIQ
Solutions combines artificial intelligence driven voice and video capture technology and services to securely manage digital content
in the most rigid security environments including courts, law enforcement, insurance, conferencing and media.

 

We
help our cybersecurity focused clients securely speed the capture, creation, and management of large volumes of information, preserve
the unique value of the spoken word and video image, and deliver meaningful data our security focused customers can utilize.

 

The
Company is a global market leader in the capture, management, and transformation of sensitive digital evidence. We enable our 1,300+
clients’ digital transformation by implementing cybersecure capture solutions, driving the migration to cloud solutions, enabling
hybrid technology services with human to machine workflow, and employing Artificial Intelligence (“AI”) tools such as speech
recognition, sentiment analysis, market specific lexicon and algorithms.

 

Revenue

 

The
recurring nature of our revenue base is a key indication of performance. Majority of our revenue is tied to major contracts and that
is expected to remain the same or increase in terms of the overall contribution to the company. Also, these customers are tied to government
entities and multinational Fortune 500 companies that provide little to no credit risk and accordingly provide a reliable revenue stream.

 

We
continue to invest globally in sales, marketing and business development to continue to diversify across segments, industries and geographies
building awareness in our global brand to increase the future revenue growth of the company.

 

Our
revenue consists primarily of technology services, software license fees, support and maintenance and other recurring fees, professional
service fees, and hardware sales. Technology service revenue consists of fees charged for recurring transcription services provided to
our customers. Software license revenue is comprised of license fees charged for the use of our software products generally licensed
under perpetual arrangements and to a lesser extent sale of third party software licenses. These license sales are more variable and
unpredictable in nature as the purchase decision and its timing fluctuate with the customers needs and budgets. Support and maintenance
and other recurring revenue primarily consist of fees charged for customer support on our software products post-delivery and, to a lesser
extent, recurring fees derived from software-as-a-service arrangements. Professional service revenue consists of fees charged for customization,
implementation, integration, training and ongoing services associated with our software products and technology services. Hardware revenue
includes the resale of third party hardware that forms part of our customer solutions. Occasionally our customers may purchase a combination
of software, maintenance, professional services and hardware, although the type, mix and quantity vary by customer and by product. 

 

    	MANAGEMENT DISCUSSION & ANALYSIS 	PAGE 3

     

    

 

VIQ SOLUTIONS
INC.

 

 

VIQ Solutions
Inc.

Management’s
Discussion and Analysis of Financial Condition and Results of Operations for 2021

 

 

Cost of
Sales

 

Cost
of sales consists primarily of staff costs, professional services and the cost of hardware and third- party licenses to fulfill customer
arrangements.

 

Selling
and Administrative Expenses

 

Selling
and administrative expenses consist primarily of personnel and related costs for our sales and marketing functions, including salaries
and benefits, contract acquisition costs including commissions earned by sales personnel, direct marketing campaigns, public relations
and other promotional activities. Selling and administrative expenses also consist primarily of personnel and related costs associated
with the administrative functions of our business including corporate, finance, and internal information system support as well as legal,
accounting, other professional fees, investor relations, occupancy costs and insurance.

 

Research
and Development Expenses

 

Research
and development expenses include personnel and related costs for ongoing research, development and product management initiatives.

 

Key
Operating Highlights during 2021

 

		•	Total
                                            revenue for the three months ended March 31, 2021 was $8,254,222, an increase of $706,018
                                            or 9% from $7,548,204 recognized in the comparative period in 2020.

		•	Gross
                                            margin for the three months ended March 31, 2021 was $4,017,835 representing 49% of
                                            revenue versus 43% of revenue in the comparative period in 2020.

		•	Adjusted
                                            EBITDA for the three months ended March 31, 2021 was $335,056, a decrease of $265,361
                                            or 44% from an Adjusted EBITDA of $600,417 recognized in the comparative period in 2020.
                                            The decrease in Adjusted EBITDA was driven primarily by professional service fees and TSX
                                            up listing fees.

		•	Net
                                            loss for the three months ended March 31, 2021 was $1,666,789, a decrease of $5,015,469
                                            or 75% from a net loss of $6,682,258 recognized in the comparative period in 2020.

 

Results
of Operations

 

Key
performance indicators that we use to manage our business and evaluate our financial results and operating performance include: revenue,
expenses, Adjusted EBITDA, and net income (loss). We evaluate our performance on these metrics by comparing our actual results to management
budgets, forecasts, and prior period performance.

 

Certain comparative
figures have been updated to reflect adjustments that were recorded in the Company’s amended filings for the three and six-months
ended June 30, 2020, which were refiled in November 2020. The adjustments related to the accounting for acquisitions, the revaluation
of the conversion feature as well as the repayment of long-term debt which were transactions that occurred in the three-months ended
March 31, 2020. 

 

    	MANAGEMENT DISCUSSION & ANALYSIS 	PAGE 4

     

    

 

VIQ
SOLUTIONS INC.

 

 

VIQ Solutions
Inc.

Management’s
Discussion and Analysis of Financial Condition and Results of Operations for 2021

 

 

The following
table sets forth a summary of our results of operations for the three months ended March 31, 2021 and 2020:

 

Unaudited

 

	 	 	Three months ended
 March 31
	 	 	Period over Period 
Change	 
	 	 	2021	 	 	2020	 	 	$	 	 	%	 
	
Revenue
	 	 	8,254,222	 	 	 	7,548,204	 	 	 	706,018	 	 	 	9	 
	Cost of sales	 	 	4,236,387	 	 	 	4,318,312	 	 	 	(81,925	)	 	 	(2	)
	Gross profit	 	 	4,017,835	 	 	 	3,229,892	 	 	 	787,943	 	 	 	24	 
	Operating Expenses	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Selling and administrative expenses	 	 	3,539,110	 	 	 	2,377,154	 	 	 	1,161,956	 	 	 	49	 
	Research and development expenses	 	 	239,663	 	 	 	252,321	 	 	 	(12,658	)	 	 	(5	)
	Gain on contingent consideration	 	 	(95,994	)	 	 	-	 	 	 	(95,994	)	 	 	-	 
	Total Operating expenses	 	 	3,682,779	 	 	 	2,629,475	 	 	 	1,053,304	 	 	 	40	 
	Adjusted EBITDA (1)	 	 	335,056	 	 	 	600,417	 	 	 	(265,361	)	 	 	(44	)
	Stock-based compensation	 	 	85,995	 	 	 	47,725	 	 	 	38,270	 	 	 	80	 
	Depreciation	 	 	73,555	 	 	 	107,854	 	 	 	(34,299	)	 	 	(32	)
	Amortization	 	 	1,174,808	 	 	 	990,697	 	 	 	184,111	 	 	 	19	 
	Interest expense	 	 	331,419	 	 	 	3,695,952	 	 	 	(3,364,533	)	 	 	(91	)
	Accretion and other financing expense	 	 	264,949	 	 	 	230,548	 	 	 	34,401	 	 	 	15	 
	Loss on revaluation of conversion feature liability	 	 	-	 	 	 	1,118,761	 	 	 	(1,118,761	)	 	 	(100	)
	Loss on repayment of long-term debt	 	 	-	 	 	 	1,290,147	 	 	 	(1,290,147	)	 	 	(100	)
	Restructuring Costs	 	 	122,216	 	 	 	-	 	 	 	122,216	 	 	 	-	 
	Other income	 	 	(3,453	)	 	 	(204	)	 	 	(3,249	)	 	 	1,593	 
	Foreign exchange (gain) loss	 	 	215,325	 	 	 	(252,249	)	 	 	467,574	 	 	 	185	 
	Loss before income taxes	 	 	(1,929,758	)	 	 	(6,628,814	)	 	 	4,699,056	 	 	 	71	 
	Current income tax recovery (expense)	 	 	41,990	 	 	 	(53,444	)	 	 	95,434	 	 	 	(179	)
	Deferred income tax recovery	 	 	220,979	 	 	 	-	 	 	 	220,979	 	 	 	-	 
	Income tax recovery (expense)	 	 	262,969	 	 	 	(53,444	)	 	 	316,413	 	 	 	592	 
	Net Loss (2)	 	 	(1,666,789	)	 	 	(6,682,258	)	 	 	5,015,469	 	 	 	75	 
	Weighted average
number of common shares outstanding	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Basic
	 	 	24,467,151	 	 	 	15,092,939	 	 	 	 	 	 	 	 	 
	Diluted	 	 	24,467,151	 	 	 	15,092,939	 	 	 	 	 	 	 	 	 
	Net income (loss) per share	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Basic	 	 	(0.07	)	 	 	(0.44	)	 	 	 	 	 	 	 	 
	Diluted	 	 	(0.07	)	 	 	(0.44	)	 	 	 	 	 	 	 	 

 

		(1)	Adjusted
                                            EBITDA, Earnings before stock-based compensation, depreciation, amortization, interest expense,
                                            accretion and other financing expense, (gain) loss on revaluation of conversion feature liability,
                                            loss on repayment of long-term debt, restructuring costs, other expense (income), foreign
                                            exchange (gain) loss, and current and deferred income tax expense (recovery), is a non-IFRS
                                            measure. Please refer to the section entitled “Non-IFRS Measures.”

		(2)	Three
                                            months ended March 31, 2021 Net loss includes $331,419 in expenses relating to interest
                                            and $1,174,808 of amortization related to the intellectual property acquired from the acquisitions
                                            and the commercial deployments of NetScribe, aiAssist, and MobileMic Pro.

  

    	MANAGEMENT DISCUSSION & ANALYSIS 	PAGE 5

     

    

 

VIQ
SOLUTIONS INC.

 

 

VIQ Solutions
Inc.

Management’s
Discussion and Analysis of Financial Condition and Results of Operations for 2021

 

 

Comparison
of the three month period ended March 31, 2021 and 2020

 

Revenue

 

Total
revenue for the three months ended March 31, 2021 was $8,254,222, an increase of $706,018, or 9%, from $7,548,204 recognized in
the comparative period in 2020. The increase in revenue is mainly driven by higher software license sales, professional service revenue,
software support and a full quarter of revenue generated from Q120 acquisitions offset by lower revenue from technology services due
to the continuing impact of COVID-19.

 

Cost
of Sales

 

Cost
of Sales for the three months ended March 31, 2021 decreased by $81,925, or 2%, to $4,236,387, from $4,318,312 for the
comparative period in 2020. The decrease in cost of sales is primarily due to $115,071 in COVID-19 wage subsidies. There were no
wage subsidies in the comparative period in 2020.

 

Gross
Profit

 

Gross
profit for the three months ended March 31, 2021 increased by $787,943, or 24%, to $4,017,835, from $3,229,892, for the comparative
period in 2020. The increase in gross profit is primarily due to higher software license sales, professional service revenue and software
support which yield a higher gross margin. In addition, increase in gross profit impacted from COVID-19 wage subsidies received in the
three months ended March 31, 2021.

 

Selling
and Administrative Expenses

 

Selling
and Administrative expenses for the three months ended March 31, 2021 increased by $1,161,956, or 49%, to $3,539,110, from $2,377,154,
for the comparative period in 2020. The Company has taken appropriate measures to manage selling and administrative expenses in conjunction
with the negative organic growth resulting from COVID-19. The increase in Selling and Administrative expenses was primarily due to professional
service fees and TSX up listing fees. In addition, Selling and Administrative expenses includes a full quarter of costs from Q120 acquisitions
and growth in the number of employees compared to the same period in 2020. Selling and Administrative expenses for the three months ended
March 31, 2021 included $188,394 in COVID-19 wage subsidies vs. $80,536 recognized in the comparative period in 2020.

 

Research
and Development Expenses

 

Research
and development expenses for the three months ended March 31, 2021 decreased by $12,658, or 5%, to $239,663, from $252,321, for
the comparative period in 2020. The decrease in Research and development expenses is due to higher amount of R&D spend being capitalized
based on meeting the qualifying test compared to the same period in 2020.

 

Gain
on Contingent Consideration

 

For
the three months ended March 31, 2021, (Gain) Loss on Contingent Consideration increased by $95,994, to a gain of $95,994, from
$0 recognized in the comparative period in 2020. This increase is mainly due to a decrease in anticipated acquisition earnout
payment accruals primarily as a result of decreases to revenue forecasts for ASC acquisition. Revenue forecasts are updated on a
quarterly basis and the related anticipated acquisition earnout payment accruals are updated accordingly.

 

    	MANAGEMENT DISCUSSION & ANALYSIS 	PAGE 6

     

    

 

VIQ
SOLUTIONS INC.

 

 

VIQ Solutions
Inc.

Management’s
Discussion and Analysis of Financial Condition and Results of Operations for 2021

 

 

Stock-Based
Compensation

 

For
the three months ended March 31, 2021, Stock Based Compensation increased by $38,270, to $85,995, from $47,725,
recognized in the same period of 2020. The increase in Stock Based Compensation is due to the impact of stock options granted in
Q220.

 

Depreciation

 

For the
three months ended March 31, 2021, Depreciation decreased by $34,299, to $73,555, from $107,854 recognized in the
comparative period in 2020. Decrease in depreciation expense is due primarily to the declining balance method of depreciation used
by the Company in that as the net book value decreases, in the absence of any significant additions, the depreciation expense is
expected to decrease over the life of the assets.

 

Amortization

 

For
the three months ended March 31, 2021, Amortization increased by $184,111, or 19%, to $1,174,808, from $990,697 recognized in the
comparative period in 2020. The increase in amortization expense primarily attributable to the launch of new products and a full quarter
of amortization expense relating to Q120 acquisitions.

 

Interest
Expense

 

For
the three months ended March 31, 2021, Interest Expense decreased by $3,364,533, to $331,419, from $3,695,952 recognized in
the comparative period in 2020. The decrease in Interest Expense is primarily due to the conversion of the convertible debenture to equity
that occurred in 2020.

 

Accretion
and Other Financing Expense

 

For
the three months ended March 31, 2021, Accretion and Other Financing expense increased by $34,401, to $264,949, from
$230,548 recognized in the comparative period in 2020. The increase in accretion and other financing expense is primarily due to
full quarter of accretion expense relating to Q120 acquisitions.

 

Loss
on Revaluation of Conversion Feature Liability

 

For
the three months ended March 31, 2021, Loss on revaluation of Conversion Feature Liability decreased by $1,118,761, from a loss
of $1,118,761 recognized in the comparative period in 2020 to $0 for the three months ended March 31, 2021. The loss recognized
in comparative period 2020 relates to the conversion of convertible debt to equity. All convertible debt has been fully converted at
the end of 2020.

 

Loss
on Repayment of Long-term Debt

 

For
the three months ended March 31, 2021, Loss on repayment of long-term debt decreased by $1,290,147, to $0, from
$1,290,147 recognized in the comparative period in 2020. The loss on repayment of long-term debt amount recorded in comparative
period 2020 was due to the re-pricing of the conversion price of the convertible debenture to C$2.18 per share resulting in a charge
of $1,290,147 reflecting the incremental fair value of the reduced exercise price.

 

Restructuring
Costs

 

For
the three months ended March 31, 2021, Restructuring Costs increased by $122,216, to $122,216, from $0 recognized in the comparative
period in 2020. The increase in Restructuring Costs is primarily due to organizational restructuring costs recorded in Q121.

 

Other
Income

 

For
the three months ended March 31, 2021, Other Income increased by $3,249, to $3,453 from $204 recognized in the comparative period
in 2020. The increase in Other Income is primarily due to interest income
on short-term deposit.

  

    	MANAGEMENT DISCUSSION & ANALYSIS 	PAGE 7

     

    

 

VIQ
SOLUTIONS INC. 

 

 

VIQ Solutions
Inc.

Management’s
Discussion and Analysis of Financial Condition and Results of Operations for 2021

 

 

Foreign
Exchange (Gain) Loss

 

For
the three months ended March 31, 2021, Foreign Exchange (Gain) Loss increased by $467,574, from a loss of $252,249 recognized in
the comparative period in 2020 to a gain of $215,325 for the three months ended March 31, 2021. The gain on foreign exchange is
due to fluctuations in the foreign exchange rates. Our businesses are organized geographically so many of our expenses are incurred in
the same currency as our revenues, which mitigates some of our exposure to currency fluctuations. Foreign exchange gain and losses are
primarily related to the unrealized foreign translation gains and losses of certain non-US dollar denominated working capital balances
to US dollars.

 

Income
Tax Recovery (Expense)

 

We
operate globally and we calculate our tax provision in each of the jurisdictions in which we conduct business. Our effective tax
rate on a consolidated basis is, therefore, affected by the realization and anticipated relative profitability of our operations in
those various jurisdictions, as well as different tax rates that apply and our ability to utilize tax losses and other credits. For
the three months ended March 31, 2021, Income Taxes, net of deferred income tax recovery, decreased by $316,413, to a
recovery of $262,969, from an expense of $53,444 in the comparative period in 2020. The change in Income Taxes is primarily
due to lower taxable income recorded in Q121.

 

Net
Loss and Earnings Per Share

 

Net
loss for the three months ended March 31, 2021 was $1,666,789 compared to net loss of $6,682,258, for the same period in 2020. On
a per weighted average share basis, this translated into a net loss per share of $0.07 in the three months ended March 31, 2021
compared to a net loss per weighted average share of $0.44 for the same period in 2020.

  

    	MANAGEMENT DISCUSSION & ANALYSIS 	PAGE 8

     

    

 

VIQ
SOLUTIONS INC.

 

 

VIQ Solutions
Inc.

Management’s
Discussion and Analysis of Financial Condition and Results of Operations for 2021

 

 

Quarterly
Results of Operations

 

The
following table sets out selected financial information for each of the eight most recent quarters, the latest of which ended March 31,
2021. Our quarterly operating results have historically fluctuated significantly and may continue to fluctuate significantly in the future.
Therefore, we believe that past operating results and period to period comparisons should not be relied upon as an indication of the
Company's future performance.

 

	 	 	(unaudited)	 
	 	 	Mar-21	 	 	Dec-20	 	 	Sep-20	 	 	Jun-20	 	 	Mar-20 *	 	 	Dec-19	 	 	Sep-19	 	 	Jun-19	 
	Revenue	 	 	8,254,222	 	 	 	7,775,674	 	 	 	8,172,800	 	 	 	8,253,015	 	 	 	7,548,204	 	 	 	6,096,550	 	 	 	6,451,077	 	 	 	6,189,458	 
	Net income (loss)	 	 	(1,666,789	)	 	 	(3,857,540	)	 	 	(345,862	)	 	 	(936,531	)	 	 	(6,682,258	)	 	 	(2,525,682	)	 	 	291,994	 	 	 	(1,519,355	)
	Weighted average number of shares outstanding:	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Basic	 	 	24,467,151	 	 	 	20,341,203	 	 	 	18,494,247	 	 	 	18,364,354	 	 	 	15,092,939	 	 	 	10,848,296	 	 	 	9,549,609	 	 	 	9,416,779	 
	Diluted	 	 	24,467,151	 	 	 	20,341,203	 	 	 	18,494,247	 	 	 	18,364,354	 	 	 	15,092,939	 	 	 	10,848,296	 	 	 	10,044,578	 	 	 	9,416,779	 
	Net income (loss) per share:	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Basic	 	 	(0.07)	 	 	 	(0.19)	 	 	 	(0.02	)	 	 	(0.05	)	 	 	(0.44	)	 	 	(0.23	)	 	 	0.03	 	 	 	(0.16	)
	Diluted	 	 	(0.07)	 	 	 	(0.19)	 	 	 	(0.02	)	 	 	(0.05	)	 	 	(0.44	)	 	 	(0.23	)	 	 	0.03	 	 	 	(0.16	)

 

*
Net Loss for Q1 2020 has been updated to reflect year end 2020 adjustments that relate to Q1 2020 mainly for loss on revaluation of conversion
feature liability amounting to $700,741.

 

Key
factors that account for the fluctuation in quarterly results include the variability in the Company’s revenue due to timing of
acquisitions and seasonality of revenue. Seasonality impacts the transcription services industry in that it is impacted in some cases
by summer holiday seasons, such as court closings in January in Australia, and the Thanksgiving and December holidays in the
US, Canada and UK. It also has a slight impact in US summer period. Our quarterly results may also fluctuate as a result of the various
acquisitions which may be completed by the Company in any given quarter. We may experience variations in our net income/(loss) on a quarterly
basis depending upon the timing of certain expenses or gains, which may include changes in provisions and acquired contract liabilities.

 

Liquidity

 

As
of March 31, 2021, we held cash of $16,020,297 as compared to $16,835,671 at December 31, 2020. We believe that ongoing operations,
working capital and associated cash flows in addition to our cash resources provide sufficient liquidity to support our ongoing business
operations and satisfy our obligations as they become due. If we continue to acquire accretive businesses we may need additional external
funding depending upon the size and timing of the potential acquisitions.

 

    	MANAGEMENT DISCUSSION & ANALYSIS 	PAGE 9

     

    

 

VIQ SOLUTIONS
INC.

 

VIQ Solutions Inc.

Management’s Discussion and Analysis of Financial Condition
and 

Results of Operations for 2021

 

Below is a summary of our cash provided by (used in) operating, investing,
and financing activities for the periods indicated:

 

	 	 	Three months ended March 31,	 
	 	 	2021	 	 	2020	 
	Cash provided by (used in) operating activities	 	 	(907,430	)	 	 	68,128	 
	Cash provided by (used in) investing activities	 	 	(1,495,933	)	 	 	(4,771,973	)
	Cash provided by (used in) financing activities	 	 	1,550,695	 	 	 	5,589,750	 
	Net increase (decrease) in cash for the period	 	 	(852,668	)	 	 	885,905	 
	Cash, beginning of period	 	 	16,835,671	 	 	 	1,707,654	 
	Effect of foreign exchange	 	 	37,294	 	 	 	(108,218	)
	Cash, end of period	 	 	16,020,297	 	 	 	2,485,341	 

 

Cash provided by (used in) operating activities

 

We used cash of $907,430 in operating
activities for the three months ended March 31, 2021. The $907,430 used for operating activities resulted from $1,666,789 in
net loss plus $1,786,729 of non-cash adjustments to net loss and $1,027,370 attributable to movements in non-cash working capital
with changes primarily arising from an increase in accounts receivable, inventories, prepaid expenses, and decrease in accounts
payable offset by contract liabilities and taxes.

 

Cash provided by (used in) investing activities

 

For the three months ended March 31, 2021,
cash used in investing activities was $1,495,933, which consisted of purchase of property and equipment of $7,540, development costs related
to internally generated intangible assets $532,298, earnout payout for ASC and WordZ $386,827, employee loan advancement $518,431 and
change in restricted cash of $50,837.

 

Cash provided by (used in) financing activities

 

Cash provided by financing activities for the
three months ended March 31, 2021 was $1,550,695, which consisted of proceeds from the exercise of stock options and warrants of
$202,857 and $2,092,276 respectively, issuance of share capital of $1,673, offset by repayment of debt of $381,157, repayment of lease
obligations of $45,268, repayment of interest on lease obligations of $7,777, and repayment of interest on debt of $311,909.

 

Debt covenants

 

As of March 31, 2021 we have satisfied all
debt covenants required under the credit facility with Crown Capital Partners. In March 2021, the Company received a waiver to remove
the Fixed Charge Coverage Ratio (“FCCR”) covenant for all four quarters of 2021, and the test of FCCR is no longer required
as the covenant.

 

    	MANAGEMENT DISCUSSION & ANALYSIS 	PAGE 10

     

    

 

VIQ SOLUTIONS INC.

 

VIQ Solutions Inc.

Management’s Discussion and Analysis of Financial Condition and 

Results of Operations for 2021

 

Contractual Obligations

 

The following table summarizes our contractual obligations as at March 31,
2021, including commitments relating to leasing contracts:

 

	 	 	2021	 	 	2022	 	 	2023	 	 	2024	 	 	2025	 	 	Total	 
	Trade and other payables	 	 	5,236,134	 	 	 	–	 	 	 	–	 	 	 	–	 	 	 	–	 	 	 	5,236,134	 
	Share appreciation rights	 	 	36,836	 	 	 	–	 	 	 	–	 	 	 	–	 	 	 	–	 	 	 	36,836	 
	Lease obligations	 	 	86,732	 	 	 	114,962	 	 	 	98,698	 	 	 	73,075	 	 	 	62,711	 	 	 	436,178	 
	Crown Capital debt	 	 	302,519	 	 	 	–	 	 	 	12,268,845	 	 	 	–	 	 	 	–	 	 	 	12,571,364	 
	Contingent Consideration - ASC	 	 	1,052,499	 	 	 	1,505,080	 	 	 	531,051	 	 	 	–	 	 	 	–	 	 	 	3,088,630	 
	Contingent Consideration - WZ	 	 	223,336	 	 	 	305,758	 	 	 	251,939	 	 	 	–	 	 	 	–	 	 	 	781,034	 
	WordZ SBA Loan	 	 	214,307	 	 	 	45,923	 	 	 	–	 	 	 	–	 	 	 	–	 	 	 	260,230	 
	WordZ promissory note	 	 	334,914	 	 	 	446,552	 	 	 	446,552	 	 	 	–	 	 	 	–	 	 	 	1,228,018	 
	Transcription Express VTB loan	 	 	71,012	 	 	 	–	 	 	 	–	 	 	 	–	 	 	 	–	 	 	 	71,012	 
	HomeTech VTB loan	 	 	180,000	 	 	 	240,000	 	 	 	240,000	 	 	 	20,000	 	 	 	–	 	 	 	680,000	 
	Total	 	$	7,738,289	 	 	$	2,658,276	 	 	$	13,837,085	 	 	$	93,075	 	 	$	62,711	 	 	$	24,389,436	 

 

The following table summarizes our contractual obligations as at December 31,
2020, including commitments relating to leasing contracts:

 

	 	 	2021	 	 	2022	 	 	2023	 	 	2024	 	 	2025	 	 	Total	 
	Trade and other payables	 	 	5,305,600	 	 	 	–	 	 	 	–	 	 	 	–	 	 	 	–	 	 	 	5,305,600	 
	Share appreciation rights	 	 	126,503	 	 	 	–	 	 	 	–	 	 	 	–	 	 	 	–	 	 	 	126,503	 
	Lease obligations	 	 	124,223	 	 	 	114,962	 	 	 	98,698	 	 	 	73,075	 	 	 	62,711	 	 	 	473,669	 
	Crown Capital debt	 	 	304,747	 	 	 	–	 	 	 	12,123,615	 	 	 	–	 	 	 	–	 	 	 	12,428,362	 
	Contingent Consideration - ASC	 	 	1,443,811	 	 	 	1,505,080	 	 	 	531,051	 	 	 	–	 	 	 	–	 	 	 	3,479,942	 
	Contingent Consideration - WZ	 	 	314,845	 	 	 	305,758	 	 	 	251,939	 	 	 	–	 	 	 	–	 	 	 	872,543	 
	WordZ SBA Loan	 	 	214,307	 	 	 	45,923	 	 	 	–	 	 	 	–	 	 	 	–	 	 	 	260,230	 
	WordZ promissory note	 	 	400,000	 	 	 	400,000	 	 	 	400,000	 	 	 	–	 	 	 	–	 	 	 	1,200,000	 
	Transcription Express VTB loan	 	 	280,531	 	 	 	–	 	 	 	–	 	 	 	–	 	 	 	–	 	 	 	280,531	 
	HomeTech VTB loan	 	 	240,000	 	 	 	240,000	 	 	 	240,000	 	 	 	20,000	 	 	 	–	 	 	 	740,000	 
	Total	 	$	8,754,566	 	 	$	2,611,723	 	 	$	13,645,303	 	 	$	93,075	 	 	$	62,711	 	 	$	25,167,380	 

 

    	MANAGEMENT DISCUSSION & ANALYSIS 	PAGE 11

     

    

 

VIQ SOLUTIONS INC.

 

VIQ Solutions Inc.

Management’s Discussion and Analysis of Financial Condition and 

Results of Operations for 2021

 

Capital Resources

 

Our objective in managing capital is to ensure
sufficient liquidity to pursue our growth strategy, fund research and development to enhance existing product offerings as well as develop
new ones to maintain our competitive advantage, pursue accretive acquisitions and provide sufficient resources to meet day- to-day operating
requirements, while managing financial risk. We intend to use our operating income and funds on hand to meet funding requirements for
the development and commercialization of our technology products and services based on anticipated market demand and working capital purposes.
Our actual funding requirements will vary depending on a variety of factors, including our success in executing our business plan, the progress of our research
and development efforts, our commercial sales, and our ability to manage our working capital requirements.

 

Our officers and senior management are responsible
for managing the capital and do so through monthly meetings and regular review of financial information. Our Board of Directors is responsible
for overseeing this process. We manage capital to ensure that there are adequate capital resources while maximizing the return to shareholders
through the optimization of the cash flows from operations and capital transactions.

 

Other commitments

 

Commitments include operating leases for office equipment and facilities.
Also, occasionally we structure some of our acquisitions with contingent consideration based on the future performance of the acquired
business. The fair value of contingent consideration recorded, partially in trade and other payables and accrued liabilities of $1,419,551
and long-term contingent consideration of $1,247,351 in our March 31, 2021 Consolidated Financial Statements was $2,666,902. Aside
from the aforementioned, we do not have any other business arrangements or any equity interests in any non-consolidated entity.

 

Contingent Off-Balance Sheet Arrangements

 

As a general practice, we have not entered into
off-balance sheet financing arrangements.

 

Transactions Between Related Parties

 

During the three months ended March 31, 2021,
the Company granted a non-revolving executive loan (the “Executive Loan”) to Sebastien Paré, President, Chief Executive
Officer and a director of the Company in the aggregate amount of USD$518,431 (CAD$657,838) to: (i) facilitate Mr. Paré
exercise of certain vested outstanding stock options; and (ii) facilitate Mr. Paré repaying certain indebtedness incurred
in connection with Mr. Paré previous exercise of convertible securities of the Company. The Executive Loan matures on February 10,
2028 and bears interest at a rate of 1.0% per annum. The Executive Loan is secured by a pledge of 175,000 common shares in the capital
of the Company held by Sebastien Paré in favour of the Company (the “Share Pledge”). Pursuant to the terms of the Share
Pledge, Mr. Paré has agreed to comply with certain covenants in favour of the Company.

 

Critical Accounting Policies and Estimates

 

The preparation of the financial statements requires management to
make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent
assets and liabilities. These estimates and assumptions are affected by management’s application of accounting policies and historical
experience, and are believed by management to be reasonable under the circumstances. Such estimates and assumptions are evaluated on an
ongoing basis and form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent
from other sources. Actual results could differ significantly from these estimates.

 

    	MANAGEMENT DISCUSSION & ANALYSIS 	PAGE 12

     

    

 

VIQ SOLUTIONS INC.

 

VIQ Solutions Inc.

Management’s Discussion and Analysis of Financial Condition and 

Results of Operations for 2021

 

Our significant accounting policies are fully
described in Note 3 to our financial statements for the years ended December 31, 2020 and 2019 which are available on SEDAR (www.sedar.com).
Certain accounting policies are particularly important to the reporting of our financial position and results of operations, and
require the application of significant judgment by our management. An accounting policy is deemed to be critical if it requires an accounting
estimate to be made based on assumptions about matters that are highly uncertain at the time the estimate is made, and if different,
estimates that reasonably could have been used, or changes in the accounting estimates that are reasonably likely to occur periodically,
could have a material impact on the financial statements. We believe that there have been no significant changes in our critical accounting
estimates for the three months ended March 31, 2021 from the years presented in our annual financial statements for the years ended
December 31, 2020 and 2019.

 

Reconciliation of Non-IFRS Measures

 

We believe that securities analysts, investors
and other interested parties frequently use non-IFRS measures in the evaluation of performance. Management also uses non-IFRS measures
in order to facilitate operating performance comparisons from period to period, prepare annual operating budgets and assess our ability
to meet our capital expenditure and working capital requirements.

 

The following is a reconciliation of Net Loss
to Adjusted EBITDA, the most directly comparable IFRS measure for the three months ended March 31, 2021 and 2020:

 

	 	 	Three months ended March 31	 
	 	 	2021	 	 	2020	 
	Net Loss	 	 	(1,666,789	)	 	 	(6,682,258	)
	Add:	 	 	 	 	 	 	 	 
	Depreciation	 	 	73,555	 	 	 	107,854	 
	Amortization	 	 	1,174,808	 	 	 	990,697	 
	Interest expense	 	 	331,419	 	 	 	3,695,952	 
	Current income tax (recovery) expense	 	 	(41,990	)	 	 	53,444	 
	Deferred income tax recovery	 	 	(220,979	)	 	 	-	 
	EBITDA	 	 	(349,976	)	 	 	(1,834,311	)
	Accretion and other financing expense	 	 	264,949	 	 	 	230,548	 
	Loss on revaluation of conversion feature liability	 	 	-	 	 	 	1,118,761	 
	Loss on repayment of long-term debt	 	 	-	 	 	 	1,290,147	 
	Restructuring Costs	 	 	122,216	 	 	 	-	 
	Other Income	 	 	(3,453	)	 	 	(204	)
	Stock-based compensation	 	 	85,995	 	 	 	47,725	 
	Foreign exchange (gain) loss	 	 	215,325	 	 	 	(252,249	)
	Adjusted EBITDA	 	 	335,056	 	 	 	600,417	 

 

    	MANAGEMENT DISCUSSION & ANALYSIS 	PAGE 13

     

    

 

VIQ SOLUTIONS INC.

 

VIQ Solutions Inc.

Management’s Discussion and Analysis of Financial Condition and 

Results of Operations for 2021

 

Internal Controls over Financial
Reporting and Disclosure Controls and Procedures

 

As the Company was a “venture
issuer” at the start of Q1 2021, and only became a “non-venture issuer” during Q1, 2021, the Company's Chief
Executive Officer (“CEO”) and Chief Financial Officer (“CFO”) file a IPO/RTO Certification of Interim
Filings Following An Initial Public Offering, Reverse Takeover or Becoming An Non-Venture Issuer (the “Certificate”)
with respect to the financial information contained in the financial statements and accompanying Management’s Discussion and
Analysis. The Certificate includes a “Note to Reader” stating that the CEO and CFO do not make any representations
relating to the establishment and maintenance of controls and other procedures designed to provide reasonable assurance that
information required to be disclosed in Company annual filings, interim filings or other reports filed or submitted under securities
legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation or a process
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with the Company’s GAAP.

 

Management works to mitigate the risk of a material
misstatement in financial reporting; however, a control system, no matter how well conceived or operated, can provide only reasonable,
not absolute, assurance that the objectives of the control system are met.

 

There have been no material changes to the internal
controls of the Company for the three months ended March 31, 2021.

 

Risk Factors

 

COVID-19: COVID-19 was declared
a global pandemic by the World Health Organization on March 11, 2020. Governments around the world have enacted emergency measures
to combat the spread of the virus. These measures which include the implementation of travel bans, self-imposed quarantine periods and
social distancing and closure of businesses have caused material disruption to businesses resulting in an economic slowdown. Governments
and central banks have responded with significant monetary and fiscal interventions designed to stabilize the financial markets. The duration
and impact of the COVID-19 outbreak is unknown at this time and it is not possible to reliably estimate the duration and severity of these
developments.

 

The Company is closely monitoring the impact of
COVID-19 on all aspects of its business.

 

The pandemic may also have an adverse impact on
many of the Company’s customers, including their ability to satisfy ongoing payment obligations to the Company, which could increase
the Company’s bad debt exposure. The future impacts of the pandemic and any resulting economic impact are largely unknown and rapidly
evolving. It is possible that the COVID-19 pandemic, the measures taken by the governments of countries affected and the resulting economic
impact may continue to adversely affect the Company’s results of operations, cash flows and financial position as well as its customers
in future periods, and this impact could be material.

 

The Governments of various jurisdictions in which
we have operations have approved legislation and taken administrative actions intended to aid businesses that have been adversely impacted
by COVID-19, including making grants or credits available to eligible entities to subsidize or offset qualifying expenses, including
employee wages and associated costs, office rent, utilities, in each case subject to limits and other specified criteria. During the
three months ended March 31, 2021, we determined that we qualified for the employee retention credit program and have received a
credit of $303,465. The credit has been recognized as a reduction in Cost of Sales of $115,071 and Selling and Administrative expenses
of $188,394. As at March 31, 2021, the amount of assistance receivable totaled $292,071. We will continue to evaluate all applicable
government relief programs and intend to apply for subsequent application periods, if we meet the qualification criteria. There can be
no assurance that COVID-19 related governmental assistance to offset our costs will be available in Q2 2021 (or thereafter), and
if so whether we will qualify for or receive any such assistance.

 

    	MANAGEMENT DISCUSSION & ANALYSIS 	PAGE 14

     

    

 

VIQ SOLUTIONS INC.

 

VIQ Solutions Inc.

Management’s Discussion and Analysis of Financial Condition and 

Results of Operations for 2021

 

Cash-flow: VIQ Solutions' business
operations are subject to all of the risks inherent in the establishment and maintenance of a developing business enterprise, such as
competition and viable operations management. The future earnings and cash flow from operations of the Company are dependent, in part,
on its ability to further develop and market its products. There can be no assurances that the Company will grow and achieve profitability.
The operations of VIQ Solutions have been funded to date by external financing and if sufficient cash flow from operations or earnings
is not generated in the future, additional financing might be required.

 

Transition to SaaS Revenue: The
Company is in the process of transitioning its software product offerings from license sales to a SaaS offering. This may cause revenue
levels to decline compared to prior periods. License sales allow the Company to recognize revenue upon the initial sale of the software
to a client. Revenues from SaaS are earned over a period of time contracted with the client and their use of the software. Initial SaaS
revenue will be lower but over the course of the contract will generally be cumulatively higher compared to license sales.

 

Fluctuations in Periodic Results: The
Company's operating results can vary substantially from period to period. Planned operating expenses are normally targeted to planned
revenue levels for the period and are incurred equally throughout the period. If expenses remain relatively fixed, but the Company's revenues
are less than planned in any quarter, the Company's operating results would be adversely affected for that quarter. In addition, incurring
unplanned expenses could adversely affect operating results for the period in which such expenses are incurred. Failure to achieve periodic
revenue, earnings, and other operating and financial results could result in an immediate and adverse effect on the market price of the
Company's common shares. The Company may not discover, or be able to confirm, revenue or earnings shortfalls until the end of a quarter,
which could result in a greater immediate and adverse effect on the price of the common shares.

 

Additional Financing and Access to Capital:
The Company may need to raise additional funds to bring its potential products to market, enhance our marketing capabilities,
and pursue potential future acquisitions. The Company's future capital requirements will depend on many factors, including continued progress
in its research and development programs, competing technological and market developments, the cost of production scale-up, effective
commercialization activities and arrangements and other factors not within the Company's control. The Company may seek additional funding
through public or private financings.

 

Identify and Acquire Suitable Acquisitions:
The Company may not be able to identify suitable new acquisitions that are available to purchase at a reasonable value. Even if
a suitable acquisition can be identified, the acquisition may not proceed if suitable terms cannot be negotiated. When conducting due
diligence on a potential acquisition, it cannot be assured that all the risks and costs inherent in the business being acquired will be
identified. If an acquisition of an identified business were to proceed in which a portion or all of the consideration consisted of cash,
additional funding may be required through public or private financings if internally generated cash resources are not sufficient.

 

Successfully Integrate Acquired Businesses:
Integration of completed business acquisitions and any future acquisitions involves a number of special risks, including the following:

 

		•	Failure to integrate successfully the personnel,
information systems, technology and operations of the acquired business;

 

    	MANAGEMENT DISCUSSION & ANALYSIS 	PAGE 15

     

    

 

VIQ SOLUTIONS INC.

 

VIQ Solutions Inc.

Management’s Discussion and Analysis of Financial Condition and 

Results of Operations for 2021

 

		•	Failure to maximize the potential financial and strategic benefits of the
acquisition;

		•	Failure to realize the expected synergies of the acquired business;

		•	Possible impairment of relationships with employees and clients as a result
of any integration of new businesses and management personnel;

		•	Impairment of goodwill; and

		•	Reductions in future operating results from the amortization of intangible
assets.

 

Future acquisitions are accompanied by the risk
that obligations and liabilities of an acquired business may not be adequately reflected in the historical financial statements of the
business and the risk that historical financial statements may be based on assumptions, which are incorrect or inconsistent with the Company’s
assumptions or approach to accounting policies. The acquisition and integration of businesses may not be managed effectively and any failure
to do so could lead to disruptions in the overall activities of the Company, a loss of clients and revenue, and increased expenses. The
Company may acquire contingent liabilities in connection with the acquisitions of business, which may be material. Best efforts are used
to identify and estimate these contingent liabilities and the likelihood that they will materialize but, these estimates could differ
materially from the liabilities actually incurred.

 

Competition: The Company competes
with a number of firms in various business segments. Competitors in Courts, for example, are different from the ones we are competing
against in public safety, medical, and legal. Some of these companies have greater financial, technological, and personnel resources than
those of the Company.

 

International Operations: The Company's
operations are currently located in Canada, the United States, and Australia and its products and services are sold internationally. There
are certain risks inherent in international operations including, but not limited to, remote management, unexpected changes in regulatory
requirements, export restrictions, tariffs and other trade barriers, difficulties in staffing and managing foreign operations, longer
payment cycles, problems in collecting accounts receivable, fluctuations in currency exchange rates, and potential adverse tax consequences,
which could have a materially adverse effect on the Company's business, operating results, and financial condition.

 

Proprietary Intellectual Property: The
Company relies on protecting its proprietary intellectual property in part through confidentiality agreements with its corporate resellers,
strategic partners, employees, consultants and certain contractors. There can be no assurance that these agreements will not be breached,
that the Company will have adequate remedies for any breach, or that the Company's trade secrets will not otherwise become known or independently
discovered by its competitors. It is possible that the Company's products or processes will infringe, or will be found to infringe, on
patents not owned or controlled by the Company. If any relevant claims of third-party patents are upheld as valid and enforceable, the
Company could be prevented from practicing the subject matter claimed in such patents or would be required to obtain licenses or redesign
its products and processes to avoid infringement. There can be no assurance that such licenses would be available at all or on terms commercially
reasonable to the Company or that the Company could redesign its products or processes to avoid infringement. Litigation may be necessary
to defend against claims of infringement or to protect trade secrets. Such litigation could result in substantial costs and diversion
of management efforts regardless of the results of such litigation and an adverse result could subject the Company to significant liabilities
to third parties, require disputed rights to be licensed or require the Company to cease using such technology.

 

    	MANAGEMENT DISCUSSION & ANALYSIS 	PAGE 16

     

    

 

VIQ SOLUTIONS INC.

 

VIQ Solutions Inc.

Management’s Discussion and Analysis of Financial Condition and 

Results of Operations for 2021

 

Product Liability Exposure: The
Company faces an inherent business risk of exposure to product liability and other claims in the event that the development or use
of its technology or prospective products is alleged to have resulted in adverse effects. While the Company has taken, and will
continue to take, what it believes are appropriate precautions, there can be no assurance that it will avoid significant liability
exposure. Although the Company currently carries product liability insurance, there can be no assurance that the Company has
sufficient coverage or can obtain sufficient coverage at a reasonable cost. An inability to obtain product liability insurance at an
acceptable cost or to otherwise protect against potential product liability claims could prevent or inhibit the commercialization of
products developed by the Company. A product liability claim could have a material adverse effect on the Company's business
financial condition and results of operations.

 

Volatility of Stock Price and Absence of
Dividends: The market price of the Company's common shares, like that of the common shares of many other software companies, has
been and is likely to be somewhat volatile. Factors such as the Company’s strategic alliances or its competitors', announcements
of technological innovations or new products by the Company or its competitors, governmental regulatory actions, developments with the
Company's collaborators, developments concerning patent or other proprietary rights of the Company or its competitors (including litigation),
period-to-period fluctuation of the Company's operating results, changes in estimates of the Company's performance by securities analysts,
market conditions for shares of software companies in general and other factors not within the control of the Company could have a significant
adverse impact on the market price of the Company’s common shares. The Company has never paid cash dividends on its common shares
and does not anticipate paying any cash dividends in the foreseeable future.

 

Foreign Currency Fluctuations: Our
monetary assets and liabilities denominated in currencies other than the United States dollar will give rise to a foreign currency gain
or loss reflected in our comprehensive earnings. To the extent the Canadian dollar or Australian dollar weakens against the United States
dollar, we may incur foreign exchange losses. Such losses would be included in our financial results and, consequently, may have an adverse
effect on our share price. As we currently have a global client base, a significant portion of our income is in US dollars and Australian
dollars. However, a significant part of our expenses are currently generated in Canadian dollars, and we expect this will continue for
the foreseeable future. The exchange rates between the Canadian dollar, the US dollar and the Australian dollar are subject to daily fluctuations
in the currency markets and these fluctuations in market exchange rates are expected to continue in the future. Such fluctuations affect
both our consolidated revenues as well as our consolidated costs. Also, changes in foreign exchange rates may affect the relative costs
of operations and prices at which we and our foreign competitors sell products in the same market. We do not currently have any currency
hedging through financial instruments.

 

Disclosure of Outstanding Share
Data

 

VIQ Solutions Inc. common shares trade on
the TSX Exchange under the symbol “VQS” and VQSLF on the OTCQX in the United States. The Company is authorized to issue
an unlimited number of common shares without par value. As at May 13, 2021 there were (i) 24,893,638 common shares issued
and outstanding, (ii) 939,600 stock options outstanding with a weighted average exercise price per common share of $3.15 CAD
expiring between 2021 and 2025, (iii) 66,667 deferred share units outstanding with an average exercise price per common share
of $1.20 CAD with no expiry date.

 

Subsequent Events

 

None

 

    	MANAGEMENT DISCUSSION & ANALYSIS 	PAGE 17Exhibit 10.1

 

TAKUNG
ART CO., LTD

 

Executive Employment
Agreement

 

This EXECUTIVE EMPLOYMENT AGREEMENT
(the "Agreement"), entered into as of June 1, 2021, by and between Takung Art Co., Ltd., a Delaware corporation (the "Company")
and Chui Kam Ng (the "Executive"). The Company and Executive are collectively referred to herein as the "Parties."
This Agreement automatically shall supersede any agreement between the Company and Executive concerning Executive's employment by the
Company.

 

RECITALS

 

A.           The
Company desires to employ the Executive as its Chief Financial Officer (CFO), and to assure itself of the services of the Executive for
the Initial Period and Extended Period (each as defined below).

 

B.           The
Executive desires to be employed by the Company as its CFO for the Initial Period and Extended Period and upon the terms and conditions
of this Agreement.

 

C.           Executive
agrees to use her best efforts, and apply her skill and experience, to the proper performance of her duties hereunder and to the business
and affairs of the Company. Executive agrees to serve the Company faithfully, diligently and to the best of her ability.

 

AGREEMENT

 

ACCORDINGLY, the Parties agree as follows:

 

1.           Term
of Employment. The Company shall employ the Executive to render services to the Company in the position and with the duties
and responsibilities described in Section 2 for a period of three (3) months starting from the date of this Agreement (the “Initial
Period”), which period shall be automatically extended for an additional nine (9) months (the "Extended Period "),
unless the Company provides notice to the Executive of its election not to extend the period prior to the expiration of the Initial Period,
or unless the Initial Period or Extended Period, as applicable, is terminated sooner in accordance with Sections 4 or 5 below or
extended upon mutual agreement of the Parties.

 

2.           Position,
Duties, Responsibilities.

 

2.1           Position. The
Executive shall render services to the Company in the positions of CFO and shall perform all services appropriate to such position. The
Executive's principal place of employment shall be at any location mutually acceptable to the board of directors of the Company and the
Executive. The Executive shall devote her best efforts to the performance of her duties. The Executive shall report
to the board of directors of the Company.

  

2.2           Execution
of Other Employment Agreements.  The Executive shall upon request of the Company execute an employment agreement with
any direct or indirect subsidiary of the Company (in each case, a "Subsidiary Employment Agreements") in accordance
with Hong Kong or China laws and regulations, in the form substantially identical to this Agreement except for adjustments or alterations
required to comply with the relevant laws and regulations of the Hong Kong or China as the case may be.

 

     

     

    

 

3.           Compensation
and Holiday.  In consideration of the services to be rendered under this Agreement, the Executive shall be entitled to the
following:

 

3.1           Base
Salary. The Company shall pay the Executive a "Base Salary" of HKD 80,000 per month, subject to adjustment
in accordance with Section 3.2 below. The Base Salary shall be paid in accordance with the Company's regularly established
payroll practices.

 

3.2           Salary
Adjustment. The Executive's Base Salary will be reviewed from time to time in accordance with the established procedures
of the Company for adjusting salaries for similarly situated employees and may be adjusted in the sole discretion of the Company.

 

3.3           Benefits. The
Executive shall be eligible to participate in the benefits made generally available by the Company to similarly-situated executives, in
accordance with the benefit plans established by the Company (including the Company’s Equity Incentive Plan), and as may be amended
from time to time in the Company's sole discretion. Nothing contained in this Article shall affect or in any way limit Executive's rights
as an executive employee of the Company to participate in any profit sharing plan, supplemental compensation arrangements or any other
fringe benefits offered by the Company to its employees as set forth in the Company's employee handbook, and compensation received by
Executive hereunder shall be in addition to the foregoing except that the severance benefits set forth in this Agreement shall be exclusive.

 

3.4           Bonus. The
Executive shall not be entitled to any bonus unless otherwise approved by the board of directors of the Company in its sole discretion.

 

3.5           Holidays. The
Executive shall be entitled to applicable statutory public holidays in each full calendar year. If the Executive's employment
commences or terminates part way through a calendar year, her entitlement to holidays will be assessed on a pro-rata basis in accordance
with the Company's holiday policy, as it may change from time to time.

 

4.           Termination
By Company.

 

4.1           Termination for
Cause. For purposes of this Agreement, "For Cause" shall mean the occurrence of any of the following,
subject only to any statutory requirement of any applicable law: (i) the failure of the Executive to properly carry out her duties after
notice by the Company of the failure to do so and a reasonable opportunity for the Executive to correct the same within a reasonable period
specified by the Company; (ii) any breach by the Executive of one or more provisions of any written agreement with, or written policies
of, the Company or her fiduciary duties to the Company likely to cause material harm to the Company and its affiliates, at the Company's
reasonable discretion, or (iii) any theft, fraud, dishonesty or serious misconduct by the Executive involving her duties or the property,
business, reputation or affairs of the Company and its affiliates. The Company may terminate the Executive's employment For
Cause at any time, without any advance notice or payment in lieu of notice. The Company shall pay to the Executive all compensation
prescribed under Section 3 hereof to which the Executive is entitled up through the date of termination, subject to any other rights or
remedies of the Company under law, and thereafter all obligations of the Company under this Agreement shall cease.

  

4.2           By Disability. In
the event Executive shall, by reason of illness or other incapacity, become unable to perform the services agreed upon herein ("Disability"
or "Disabled"), the Company shall continue to compensate Executive for six (6) months commencing from the date of such Disability
at her base monthly salary less any amounts actually received by Executive from the disability insurance policies carried by the Company
for the benefit of Executive pursuant to Section 3. "Disability" shall mean if, as a result of Executive's incapacity due
to physical or mental illness, Executive shall have been absent from the full-time performance of Executive's duties with the Company
for three (3) consecutive months, and within thirty (30) days after written notice of termination is given Executive shall not have returned
to the full-time performance of Executive's duties. The determination of Disability will be established by the Company’s benefit
provider. The determination of such benefit provider shall be made in writing to the Company and Executive and shall be final and conclusive
for purposes of this Agreement.

 

     

     

    

 

4.3           Other
Termination by Company. In addition to Sections 4.1 through 4.2, the Company may at any time terminate the employment
of the Executive without cause: (i) at any time during the Initial Period, in which case the Executive will not be eligible to
receive any severance; or (ii) by giving one (1) month written notice to the Executive during the Extended Period, in which case the
Executive will be eligible to receive an amount equal to one (1) month of the then-current Base Salary of the Executive payable in
the form of salary continuation (the “Severance”). The Executive's eligibility for Severance is conditioned on the
Executive having first signed a Termination Certificate in the form attached as Exhibit A. The Executive
shall not be entitled to any Severance payments if the Executive's employment is terminated For Cause, by death or by Disability (as
provided above) or if the Executive's employment is terminated by the Executive for any reason other than Good Reason, as defined
below.

 

5.           Termination
By Executive.

 

5.1          Termination
by Executive other than for Good Reason. The Executive may terminate employment with the Company at any time for any reason
or no reason at all, upon three (3) months' advance written notice. During such notice period the Executive shall continue
to diligently perform all of the Executive's duties hereunder. The Company shall have the option, in its sole discretion, to
make the Executive's termination effective at any time prior to the end of such notice period as long as the Company pays the Executive
all compensation under Section 3 hereof to which the Executive is entitled up through the actual termination date. Thereafter
all obligations of the Company shall cease. Unless the Executive terminates her employment for Good Reason, as provided in
Section 5.2, no Severance or other separation benefits shall be paid to the Executive.

 

5.2          Termination
for Good Reason. The Executive's termination shall be for Good Reason (as defined below) if the
Executive provides written notice to the Company of the Good Reason within ten (10) days of the event constituting Good Reason and provides
the Company with a period of ten (10) days to cure the Good Reason and the Company fails to cure the Good Reason within that period.  For
purposes of this Agreement, "Good Reason" shall mean, without the Executive’s express written consent, the occurrence
of any of the following circumstances: (a) The assignment to Executive of any duties inconsistent with Executive’s status as an
executive officer of the Company or a substantial adverse alteration in the nature or status of Executive’s responsibilities from
those in effect upon the date hereof; (b) A reduction by the Company by more than twenty percent (20%) in Executive’s Base Salary
as in effect on the date hereof; (c) The failure by the Company, without Executive’s consent, to pay to Executive any portion of
Executive’s compensation due hereunder more than twice in any 12 month period except pursuant to an across-the-board compensation
deferral similarly affecting all executives of the Company; (d) The failure by the Company to continue to provide Executive with benefits
or arrangements (including, without limitation, income tax services, car allowances, and other fringe benefits) at least as favorable
to those enjoyed by Executive upon the start of employment hereunder, the taking of any action by the Company which would directly or
indirectly materially reduce any of such benefits or deprive Executive of any material fringe benefit enjoyed by Executive upon the start
of employment hereunder. Executive’s continued employment shall not constitute consent to, or a waiver of rights with respect to,
any circumstance constituting Good Reason hereunder. Upon occurrence of any of the foregoing events which Executive believes constitutes
 "Good Reason," Executive must notify the Company in writing within ten (10) days and give the Company ten (10) days to cure
or correct the alleged action or failure. After the expiration of twenty (20) days, Executive may quit for "Good Reason" by
giving written notice within an additional fourteen (14) days.

 

6.           Termination
Obligations.

 

The Executive agrees that on or before termination
of employment, she will promptly return to the Company all documents and materials of any nature pertaining to her work with the Company,
including all originals and copies of all or any part of any Proprietary Information or Inventions (as defined below) along with any and
all equipment and other tangible and intangible property of the Company. The Executive agrees not to retain any documents or
materials or copies thereof containing any Proprietary Information or Inventions.

 

     

     

    

 

The Executive further agrees
that: (i) all representations, warranties, and obligations under Articles 6, 7, 8, 9, 10, 11, 12, 14.1, 14.2, 14.3
and 14.4 contained in this Agreement shall survive the termination of the Initial Period and Extended Period, as applicable;
(ii) the Executive's representations, warranties and obligations under Articles 6, 7, 8, 9, 10, 11, 12, 14.1, 14.2, 14.3 and
14.4 shall also survive the expiration of this Agreement; and (iii) following any termination of the Initial Period or Extended
Period, as applicable, the Executive shall fully cooperate with the Company in all matters relating to her continuing obligations
under this Agreement, including but not limited to the winding up of pending work on behalf of the Company, the orderly transfer of
work to the other employees of the Company, and the defense of any action brought by any third party against the Company that
relates in any way to the Executive's acts or omissions while employed by the Company. The Executive also agrees to sign
and deliver the Termination Certificate attached hereto as Exhibit A prior to her termination of employment with
the Company.

 

7.           Post-Termination
Activity.

 

7.1           No
Use of Proprietary Information. The Executive acknowledges that the pursuit of the activities forbidden by this subsection
would necessarily involve the use or disclosure of Proprietary Information in breach of this Agreement, but that proof of such a breach
would be extremely difficult. To forestall such disclosure, use, and breach, and in consideration of the employment under this
Agreement, the Executive also agrees that while employed by the Company, and for a period of six (6) months after termination of the Executive's
employment, the Executive shall not, directly or indirectly:

 

(i)           divert
or attempt to divert from the Company or any Affiliate ("Affiliate" shall mean any person or entity that directly, or
indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with such entity). For
the purposes of this definition "control" means the possession, directly or indirectly, of the power to direct or cause
the direction of the management and policies of a person, whether through the ownership of voting securities, by contract or otherwise,
and includes (a) ownership directly or indirectly of 50% or more of the shares in issue or other equity interests of such person, (b)
possession directly or indirectly of 50% or more of the voting power of such person or (c) the power directly or indirectly to appoint
a majority of the members of the board of directors or similar governing body of such person, and the terms "controlling"
and "controlled" have meanings correlative to the foregoing) any business of any kind in which it is engaged, including,
without limitation, soliciting business from or performing services for, any persons, company or other entity which at any time during
the Executive's employment by the Company is a client, supplier, or customer of the Company or prospective client, supplier, or customer
of the Company if such business or services are of the same general character as those engaged in or performed by the Company; 

 

(ii)          solicit
or otherwise induce any person to terminate her employment or consulting relationship with the Company or any Affiliate; or

 

(iii)        
engage, invest or assist in any business activity that directly or indirectly competes with any business plan of the Company or any Affiliate.

 

In addition, because the Executive acknowledges
the difficulty of establishing when any intellectual property, invention, or proprietary information is first conceived or developed by
the Executive, or whether it results from access to Proprietary Information or the Company equipment, supplies, facilities, or data, the
Executive agrees that any intellectual property, invention, or proprietary information shall be reported to the Company and, unless proven
otherwise to the reasonable satisfaction of the Company, shall be presumed to be an Invention (as defined below) for the purpose of this
Agreement and shall be subject to all terms and conditions hereof, if reduced to practice by the Executive or with the aid of the Executive
within six (6) months after termination of the Initial Period or Extended Period, as applicable.

 

7.2          No
Competition. Notwithstanding Section 7.1 above, while employed by the Company and for a period of six (6) months
after the termination of the Executive's employment with the Company for any reason whatsoever, the Executive shall not, directly or
indirectly, as an executive, employer, employee, consultant, agent, principal, partner, manager, stockholder, officer, director, or
in any other individual or representative capacity, engage, aid, counsel or participate in any business within Hong Kong and the
People’s Republic of China that is competitive with the business of the Company or any Affiliate. Notwithstanding
the foregoing, the Executive may own less than one percent (1%) of any class of stock or security of any corporation listed on an
internationally recognized securities exchange which competes with the Company.

 

     

     

    

 

7.3          Enforceability. The
covenants of this Article 7 are several and separate, and the unenforceability of any specific covenant shall not affect the provisions
of any other covenant. If any provision of this Article 7 relating to the time period or geographic area of the restrictive
covenants shall be declared by a court of competent jurisdiction to exceed the maximum time period or geographic area, as applicable,
that such court deems reasonable and enforceable, then this Agreement shall automatically be considered to have been amended and revised
to reflect the maximum time period or geographic area that such court deems enforceable.

 

7.4          Independent
Covenants. All of the covenants in this Article 7 shall be construed as an agreement independent of any other provision
in this Agreement, and the existence of any claim or cause of action of the Executive against the Company or any of its Affiliates, whether
predicated on this Agreement or otherwise, shall not constitute a defense to the enforcement by the Company of such covenants.

 

 

8.           Proprietary
Information.

 

The Executive agrees during her employment with
the Company and within three (3) years thereafter, to hold in strictest confidence and trust, and not to use or disclose to any person,
firm or corporation any Proprietary Information without the prior written consent of the Company, except as necessary in carrying out
her duties as an employee of the Company for the benefit of the Company. "Proprietary Information" means any
information of a proprietary, confidential or secret nature that may be disclosed to the Executive that relates to the business of the
Company or of any parent, subsidiary, Affiliate, customer or supplier of the Company or any other party with whom the Company agrees to
hold information of such party in confidence ("Relevant Parties"). Such Proprietary Information includes,
but is not limited to, Inventions (as defined below), research, product plans, products, services, business strategies, personnel information,
customer lists, customers, markets, technical information, forecasts, marketing, finances or other business information of the Company
and its Affiliates. This information shall remain confidential whether it was disclosed to the Executive either directly or
indirectly in writing, orally or by drawings or observation. The Executive understands that Proprietary Information does not
include any of the foregoing items which has become publicly known and made generally available through no wrongful act of the Executive
or others who were under confidentiality obligations as to the items involved.

 

9.           Former
Employer Information.

 

The Executive agrees that she will not, during
her employment with the Company, improperly use or disclose any proprietary information or trade secrets, or bring onto the premises of
the Company any unpublished document or proprietary information belonging to any former or concurrent employer or other person or entity
(excluding any direct or indirect subsidiary of the Company).

 

10.         Third
Party Information.

 

The Executive recognizes that the Company has received
and in the future will receive confidential or proprietary information from third parties. The Executive agrees to hold all
such confidential or proprietary information in the strictest confidence and trust, and not to disclose it to any person, firm or corporation
or to use it except as necessary in carrying out her work for the Company consistent with the Company's agreement with such third party.

 

11.         No
Conflict.

 

The Executive represents and warrants that
the Executive's execution of this Agreement, her employment with the Company, and the performance of her proposed duties under this
Agreement shall not violate any obligations she may have to any former employer or other party, including any obligations with
respect to proprietary or confidential information or intellectual property rights of such party or require the consent or approval
of any third party.

 

     

     

    

 

12.         Inventions.

 

12.1        Inventions
Retained and Licensed. The Executive has attached, as Exhibit B, a list describing all inventions, original
works of authorship, developments, improvements, and trade secrets which were made by the Executive prior to the Executive's employment
with the Company ("Prior Inventions"), which belong to the Executive, and which relate to the Company's actual and/or
proposed business, products or research and development. If, in the course of her employment with the Company, the Executive
incorporates into a Company product, process or machine a Prior Invention owned by the Executive or in which the Executive has an interest,
the Company is hereby granted and shall have a non-exclusive, royalty-free, irrevocable, perpetual, worldwide license to make, have made,
modify, use and sell such Prior Invention as part of or in connection with such product, process or machine.

 

12.2        Assignment
of Inventions. The Executive agrees that she will promptly make full written disclosure to the Company, will hold in trust
for the sole right and benefit of the Company, and hereby irrevocably assigns to the Company, or its designee, all the Executive's right,
title, and interest in and to any and all inventions, original works of authorship, developments, concepts, improvements, designs, drawings,
discoveries, ideas, formulas, processes, compositions of matter, software, databases, mask works, computer programs (including all source
codes) and related documentation, algorithms, engineering and reverse engineering, technology, hardware configuration information, logos,
trade names, trademarks, patents, patent applications, copyrights, trade secrets or know-how, which the Executive may solely or jointly
conceive or develop or reduce to practice, or cause to be conceived or developed or reduced to practice ("Inventions"),
while the Executive is employed by the Company. The Executive further acknowledges that all original works of authorship which
are made by the Executive (solely or jointly with others) within the scope of and during her employment with the Company and which are
protectable by copyright are "works made for hire," as that term is defined in the United States Copyright Act and that
the Company will be considered the author and owner of such works. The Executive understands and agrees that the decision whether
or not to commercialize or market any Invention developed by the Executive solely or jointly with others is within the Company's sole
discretion and for the Company's sole benefit and that no royalty will be due to the Executive as a result of the Company's efforts to
commercialize or market any such Invention.

 

12.3        Waiver
of Moral Rights. To the utmost extent legally permitted, the Executive also hereby forever waives and agrees never to assert
any and all Moral Rights (as defined below) he may have in or with respect to any Invention, even after termination of her work on behalf
of the Company. "Moral Rights" mean any rights to claim authorship of an Invention to object to or prevent
the modification of any Invention, or to withdraw from circulation or control the publication or distribution of any Invention, and any
similar right, existing under judicial or statutory law of any country in the world, or under any treaty, regardless of whether or not
such right is denominated or generally referred to as a "moral right."

 

12.4        Maintenance
of Records. The Executive agrees to keep and maintain adequate and current written records of all Inventions made by the
Executive (solely or jointly with others) during the Executive's employment with the Company. The records will be in the form
of notes, sketches, drawings, and any other format that may be specified by the Company. The records will be provided to, and
remain the sole property of, the Company at all times.

 

12.5        Patent
and Copyright Registrations. The Executive agrees to assist the Company, or its designee, at the Company's expense,
in every proper way, to secure the Company's rights in the Inventions and any copyrights, patents, mask work rights, trade secret
rights or other intellectual property rights relating thereto in any and all countries. The Executive will disclose to
the Company all pertinent information and data which the Company deems necessary for the execution of all applications,
specifications, oaths, assignments and execute all instruments necessary to apply for and obtain such rights and in order to assign
and convey to the Company, its successors, assigns, and nominees, the sole and exclusive right, title and interest in and to such
Inventions, and any copyrights, patents, mask work rights, or other intellectual property rights relating thereto. The
Executive further agrees that the Executive's obligation to execute or cause to be executed, when it is in the Executive’s
power to do so, any such instrument or papers shall continue after the termination of this Agreement. If the Company is
unable, because of the Executive's mental or physical incapacity or for any other reason, to secure her signature to apply for or to
pursue any application for any patents or copyright registrations covering the Inventions assigned to the Company as above, then the
Executive hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as her agent and
attorney in fact, to act for and in the Executive's behalf and stead to execute and file any such applications and to do all other
lawfully permitted acts to further the prosecution and issuance of letters, patent or copyright registrations thereon with the same
legal force and effect as if executed by the Executive.

 

     

     

    

 

13.         Alternative
Dispute Resolution.

 

Except with respect to any proceeding brought under Section 7 hereof,
the Company and Executive mutually agree that any controversy or claim arising out of or relating to this Agreement or the breach thereof,
or any other dispute between the parties, shall be submitted to mediation before a mutually agreeable mediator, which cost is to be borne
equally by the parties hereto. In the event the Parties fail to agree on a mediator, or mediation is unsuccessful in resolving the claim
or controversy within one (1) month after the commencement of mediation, such claim or controversy shall be resolved by arbitration in
Hong Kong. Any dispute, controversy, difference or claim arising out of or relating to this Agreement, including the existence, validity,
interpretation, performance, breach or termination thereof or any dispute regarding non-contractual obligations arising out of or relating
to it shall be referred to and finally resolved by arbitration administered by the Hong Kong International Arbitration Centre (HKIAC)
under the UNCITRAL Arbitration Rules in force when the Notice of Arbitration is submitted , as modified by the HKIAC Procedures for the
Administration of International Arbitration. The law of this arbitration clause shall be Hong Kong law. The seat of arbitration shall
be in Hong Kong. The number of arbitrators shall be one. The arbitration proceedings shall be conducted in English.

 

14.         Miscellaneous.

 

14.1         Continuing
Obligations. The obligations in this Agreement will continue in the event that the Executive is hired, renders services
to or for the benefit of or is otherwise retained at any time by any present or future Affiliates of the Company. Any reference
to the Company in this Agreement will include such Affiliates. Upon the expiration or termination for any reason whatsoever
of this Agreement, the Executive shall forthwith resign from any employment of office with an Affiliate of the Company unless the board
of directors of the Company requests otherwise.

 

14.2        Notification. The
Executive hereby authorizes the Company to notify her actual or future employers of the terms of this Agreement and her responsibilities
hereunder.

 

14.3        Name and
Likeness Rights. The Executive hereby authorizes the Company to use, reuse, and to grant others the right to use and reuse,
her name, photograph, likeness (including caricature), voice, and biographical information, and any reproduction or simulation thereof,
in any media now known or hereafter developed (including but not limited to film, video and digital or other electronic media), both during
and after her employment, for whatever purposes the Company deems necessary.

 

14.4        Injunctive
Relief. The Executive understands that in the event of a breach or threatened breach of this Agreement by her, the Company
may suffer irreparable harm and will therefore be entitled to injunctive relief to enforce this Agreement.

 

14.5        Entire
Agreement. This Agreement, including the exhibits attached hereto, is intended to be the final, complete, and exclusive
statement regarding their subject matter, except for other agreements specifically referenced herein. Unless otherwise specifically
provided for herein, this Agreement supersedes all other prior and contemporaneous agreements and statements pertaining to this subject
matter, and may not be contradicted by evidence of any prior or contemporaneous statements or agreements. To the extent that
the practices, policies, or procedures of the Company, now or in the future, apply to the Executive and are inconsistent with the terms
of this Agreement, the provisions of this Agreement shall control.

 

     

     

    

 

14.7        Amendments,
Renewals and Waivers. This Agreement may not be modified, amended, renewed or terminated except by an instrument in writing,
signed by the Executive and by a duly authorized representative of the Company other than the Executive.  No failure to exercise
and no delay in exercising any right, remedy, or power under this Agreement shall operate as a waiver thereof, nor shall any single or
partial exercise of any right, remedy, or power under this Agreement preclude any other or further exercise thereof, or the exercise of
any other right, remedy, or power provided herein or by law or in equity.

 

14.8        Assignment;
Successors and Assigns. The Executive agrees that she will not assign, sell, transfer, delegate or otherwise dispose of,
whether voluntarily or involuntarily, or by operation of law, any rights or obligations under this Agreement, nor shall the Executive's
rights be subject to encumbrance or the claims of creditors. Any purported assignment, transfer, or delegation shall be null
and void. Nothing in this Agreement shall prevent the consolidation of the Company with, or its merger into, any other corporation,
or the sale by the Company of all or substantially all of its properties or assets, or the assignment by the Company of this Agreement
and the performance of its obligations hereunder to any successor in interest. In the event of a change in ownership or control
of the Company, the terms of this Agreement will remain in effect and shall be binding upon any successor in interest. Notwithstanding
and subject to the foregoing, this Agreement shall be binding upon and shall inure to the benefit of the parties and their respective
heirs, legal representatives, successors, and permitted assigns, and shall not benefit any person or entity other than those enumerated
above.

 

14.9        Indemnification. The
Company shall indemnify the Executive, to the maximum extent permitted by applicable law, against all costs, charges and expenses incurred
or sustained by the Executive in connection with any action, suit or proceeding to which she may be made a party by reason of being an
officer, director or employee of the Company or of any subsidiary or affiliate of the Company or any other corporation for which the Executive
serves in good faith as an officer, director, or employee.  The Company will cover Executive under its directors and officers liability
insurance in the same amount and to the same extent as the Company covers its other officers and directors.

 

14.10      Notices. All
notices and other communications given or made pursuant hereto shall be in writing and shall be deemed to have been duly given or made
as of the date delivered or mailed if delivered personally or by nationally recognized courier or mailed by registered mail (postage prepaid,
return receipt requested) or by telecopy to the parties at the following addresses (or at such other address for a party as shall be specified
by like notice, except that notices of changes of address shall be effective upon receipt):

 

	To:	Company
	Contact Address:	Takung Art Co., Ltd
	 	Room 709, Tower 2 ,Admiralty Center, 18 Harcourt Road, Admiralty, Hong Kong
	Attention:	Sze Chan, Vice President
	 	 
	To:	Executive
	Contact Address:	Room 709, Tower 2 ,Admiralty Center, 18 Harcourt Road, Admiralty, Hong Kong
	 	 
	Attention:	Chui Kam Ng

 

14.11      Waiver
of Immunity. To the extent that any Party (including its assignees of any such rights or obligations hereunder) may
be entitled, in any jurisdiction, to claim for itself (or himself or herself) or its revenues or assets or properties, immunity from
service of process, suit, the jurisdiction of any court, an interlocutory order or injunction or the enforcement of the same against
its property in such court, attachment prior to judgment, attachment in aid of execution of an arbitral award or judgment
(interlocutory or final) or any other legal process, and to the extent that, in any such jurisdiction there may be attributed such
immunity (whether claimed or not), such Party hereby irrevocably waives such immunity.

 

     

     

    

 

14.12      Severability;
Enforcement. If any provision of this Agreement, or its application to any person, place, or circumstance, is held by an
arbitrator or a court of competent jurisdiction to be invalid, unenforceable, or void, such provision shall be enforced (by blue-penciling
or otherwise) to the maximum extent permissible under applicable law, and the remainder of this Agreement and such provision as applied
to other persons, places, and circumstances shall remain in full force and effect.

 

14.13      Governing
Law. This Agreement shall in all respects be construed and enforced in accordance with and governed by the laws of Hong
Kong, without regard to principles of conflict of laws.

 

14.14      Interpretation. This
Agreement shall be construed as a whole, according to its fair meaning, and not in favor of or against any party. Sections
and section headings contained in this Agreement are for reference purposes only, and shall not affect in any manner the meaning or interpretation
of this Agreement.  Whenever the context requires, references to the singular shall include the plural and the plural the singular.  References
to one gender include both genders.

  

14.15      Counterparts. This
Agreement may be executed in any number of counterparts, each of which shall be deemed an original of this Agreement, but all of which
together shall constitute one and the same instrument.

 

     

     

    

 

EXECUTIVE ACKNOWLEDGEMENT.  The Executive
acknowledges (i) that she has consulted with or has had the opportunity to consult with independent counsel of her own choice concerning
this Agreement and has been advised to do so by the Company, and (ii) that she has read and understands the Agreement, is fully aware
of its legal effect, and has entered into it freely based on her own judgment. The Executive hereby agrees that her obligations
set forth in Sections 7, 8, and 9 hereof and the definitions of Proprietary Information and Inventions contained therein shall be equally
applicable to Proprietary Information and Inventions relating to any work performed by the Executive for the Company prior to the execution
of this Agreement.

 

The parties have duly executed this Agreement as
of the date first written above.

 

	 	EXECUTIVE:
	 	 	 	 
	 	/s/ Chui
Kam Ng	 
	 	Name: Chui Kam Ng
	 	 	 	 
	 	COMPANY:
	 	 	 	 
	 	Takung Art Co., Ltd
	 	 	 	 
	 	By:	/s/ Sze Chan	 
	 	Name: Sze Chan
	 	Title:   Vice President

 

     

     

    

 

EXHIBIT A

 

TERMINATION CERTIFICATE

 

This is to certify that I have returned all property of Takung Art
Co., Ltd. (the "Company") and the Relevant Parties, including, without limitation, all books, manuals, records, models,
drawings, reports, notes, contracts, lists, blueprints, and other documents and materials, electronic data recorded or retrieved by any
means, Proprietary Information, and equipment furnished to or prepared by me in the course of or incident to my employment with the Company,
and that I did not make or distribute any copies of the foregoing.

 

I further certify that I have reviewed the Executive Employment Agreement
(the "Agreement") signed by me and that I have complied with and will continue to comply with all of its terms, including,
without limitation, (i) the reporting of any Inventions or any improvement, rights, or claims related to the foregoing, conceived
or developed by me and covered by the Agreement; (ii) the preservation as confidential of all Proprietary Information pertaining
to the Company and the Relevant Parties; (iii) not participating in any business competitive with the business of the Company; (iv)
not acting as the legal representative or an executive officer of any other company within and outside Hong Kong, and (v) the reporting
of any remuneration paid to me due to any employment or self-employment during the severance period, if any.  This certificate
in no way limits my responsibilities or liabilities to the Company or the Company's rights under the Agreement.

 

On termination of my employment with the Company, I will be employed
by [name of new employer] in the [division name] division and I will be working in connection with the
following projects:

 

[generally describe the projects]

 

	 
	 
	 
	 

 

	Date:	 	 	 
	 	 	 	Print Executive's Name
	 	 	 	 
	 	 	 	 
	 	 	 	Executive's Signature

 

     

     

    

 

EXHIBIT B

 

LIST OF PRIOR INVENTIONS

AND ORIGINAL WORKS OF AUTHORSHIP

 

 

Title                   Date              Identifying
Number or Brief Description

 

 

 

______X______                             No
inventions or improvements

____________                                Additional
Sheets Attached

 

	Signature of Executive:	/s/	 

Printed Name of Executive: Chui Kam Ng

Date:   June , 2021

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00328-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00328-of-00352.parquet"}]]